<SEC-DOCUMENT>0001193125-25-118856.txt : 20250513
<SEC-HEADER>0001193125-25-118856.hdr.sgml : 20250513
<ACCEPTANCE-DATETIME>20250513162528
ACCESSION NUMBER:		0001193125-25-118856
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250513
DATE AS OF CHANGE:		20250513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Hyperfine, Inc.
		CENTRAL INDEX KEY:			0001833769
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-275449
		FILM NUMBER:		25940555

	BUSINESS ADDRESS:	
		STREET 1:		351 NEW WHITFIELD STREET
		CITY:			GUILFORD
		STATE:			CT
		ZIP:			06437
		BUSINESS PHONE:		866-796-6767

	MAIL ADDRESS:	
		STREET 1:		351 NEW WHITFIELD STREET
		CITY:			GUILFORD
		STATE:			CT
		ZIP:			06437

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HealthCor Catalio Acquisition Corp.
		DATE OF NAME CHANGE:	20201124
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d917572d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(5) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-275449</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMENDMENT NO. 2 DATED MAY&nbsp;13, 2025 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>to Prospectus
Supplement Dated November&nbsp;22, 2023 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(To Prospectus Dated November&nbsp;22, 2023) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Hyperfine, Inc. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g917572g0509202417588.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Up to $50,000,000 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Class&nbsp;A Common Stock </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Amendment No.&nbsp;2 to Prospectus Supplement, or this Amendment, amends our prospectus supplement dated November&nbsp;22, 2023, as
amended by Amendment No.&nbsp;1 dated March&nbsp;22, 2024, or the Prospectus Supplement. This Amendment should be read in conjunction with the Prospectus Supplement and the accompanying prospectus, or the Prospectus, included in the Registration
Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> filed with the Securities and Exchange Commission on November&nbsp;9, 2023 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-275449),</FONT> and is qualified by reference thereto,
except to the extent that the information herein amends or supersedes the information contained in the Prospectus Supplement or the Prospectus. This Amendment is not complete without, and may only be delivered or utilized in connection with, the
Prospectus Supplement and the Prospectus, and any future amendments or supplements thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We entered into our sales agreement with B.
Riley Securities, Inc., or B. Riley, dated November&nbsp;9, 2023, or the Sales Agreement, relating to our Class&nbsp;A common stock, par value $0.0001 per share, offered by the Prospectus Supplement and the Prospectus. Pursuant to the Prospectus
Supplement and in accordance with the terms of the Sales Agreement, we may offer and sell our Class&nbsp;A common stock having an aggregate offering price of up to $50,000,000 from time to time through or to B. Riley, acting as sales agent or
principal. As of May&nbsp;13, 2025, we have sold 898,119 shares of our Class&nbsp;A common stock pursuant to the Sales Agreement for aggregate gross proceeds of approximately $1.01&nbsp;million in accordance with the Sales Agreement under the
Prospectus Supplement. Consequently, up to approximately $48.99&nbsp;million remains available for sale under the Sales Agreement pursuant to this Amendment and the Prospectus Supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Class&nbsp;A common stock is listed on The Nasdaq Global Market under the symbol &#147;HYPR.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are filing this Amendment to amend the Prospectus Supplement to increase the amount of our Class&nbsp;A common stock we are eligible to
sell pursuant to the Sales Agreement since we are no longer subject to General Instruction I.B.6 of Form <FONT STYLE="white-space:nowrap">S-3.</FONT> As of March&nbsp;17, 2025, the date of filing of our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2024, the aggregate market value of our outstanding Class&nbsp;A common stock held by <FONT STYLE="white-space:nowrap">non-affiliates,</FONT> or the public float, was
$95,821,911, which was calculated based on 56,036,205 shares of our outstanding Class&nbsp;A common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> as of February&nbsp;6, 2025, and at a price of $1.71 per share, the closing
price of our Class&nbsp;A common stock on February&nbsp;6, 2025. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the terms of the Sales Agreement, we may offer and
sell shares of our Class&nbsp;A common stock having an aggregate offering price of up to $50,000,000 from time to time through or to B. Riley. If our public float decreases in the future such that we become subject to the offering limitations
contained in General Instruction I.B.6 of Form <FONT STYLE="white-space:nowrap">S-3,</FONT> we will file another amendment to the Prospectus Supplement prior to making additional sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Investing in our Class&nbsp;A common stock involves a high degree of risk. See the information contained under &#147;Risk Factors&#148; of
the Prospectus Supplement, the Prospectus, and under similar headings in the documents incorporated by reference therein for a discussion of the factors you should carefully consider before deciding to purchase these securities. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this Amendment, the Prospectus Supplement or the Prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>B. Riley Securities </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this Amendment No.&nbsp;2 to Prospectus Supplement is May&nbsp;13, 2025. </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g917572g0509202417588.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g917572g0509202417588.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  C 04# 2(  A$! Q$!_\0
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DSP_\\8_^^11]GA_YXQ_]\BBBE9#NR0 * %  '0 4444Q'__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
